M

MyOme Tech Stack

Whole-genome sequencing analysis for clinical decision support

Biotechnology Research Palo Alto, California 11–50 employees Privately Held

MyOme runs a bioinformatics operation built on Illumina + PacBio sequencing hardware, Python + R + Nextflow pipelines, and Kubernetes-deployed infrastructure on AWS. The tech stack and active project list—targeted NGS workflows, variant call quality checks, production test dashboards, clinical trial design—signal a company transitioning from research-grade analysis toward operational maturity: they're building monitoring systems, cost controls, and multi-site trial orchestration. Hiring is decelerating but still active across engineering and healthcare roles, with a leadership gap (only one director-level hire) despite the operational complexity.

Tech Stack 17 technologies

Core StackLinux Python AWS Docker Kubernetes Terraform GitHub Actions HubSpot Django Illumina PacBio R Nextflow Snakemake WDL SQL Google Workspace

What MyOme Is Building

◆Challenges

Improving test performance monitoring
Streamlining lab operations
Scaling bioinformatics pipelines
Ensuring accurate genetic test results
Executing large-scale multi-site trials
Cost monitoring and management
Secure genomic data storage

▲Active Projects

Targeted ngs workflow design
Benchmarking truth sets
Roadmap integration
Scalable cloud-based pipelines
Production-grade systems for clinical decision-making
Test performance monitoring systems
Production test workflows dashboards
Variant call quality checks
Clinical trial design and implementation
Trial operationalization with cros

Hiring Activity

Decelerating10 roles · 2 in 30d

Department

Engineering

4

Healthcare

3

Data

1

Marketing

1

Research

1

Seniority

Mid

3

Senior

3

Lead

2

Director

1

Manager

1

Company intelligence

Find more companies like MyOme by tech stack, pain points and active projects

Get started free

About MyOme

MyOme delivers whole-genome sequencing reports to patients and providers through clinical-grade bioinformatics. The core offering combines Illumina and PacBio sequencing with in-house pipelines (Nextflow, Snakemake, WDL) to produce genomic reports tied to actionable lifestyle and treatment decisions. The company operates in the 11–50 employee range and is headquartered in Palo Alto, California. Current work spans targeted NGS workflow design, benchmarking accuracy against truth sets, building dashboards for test performance monitoring, and designing multi-site clinical trials. Pain points center on scaling pipelines, securing genomic data, managing costs, and streamlining lab operations.

HeadquartersPalo Alto, California

Company Size11–50 employees

Hiring MarketsUnited States

Frequently Asked Questions

What tech stack does MyOme use for sequencing analysis?

MyOme uses Illumina and PacBio sequencing platforms, with analysis pipelines in Python, R, Nextflow, and Snakemake. Infrastructure runs on AWS via Docker and Kubernetes, with GitHub Actions for CI/CD and Terraform for IaC.

What is MyOme working on?

MyOme is building targeted NGS workflows, variant call quality checks, production test dashboards, and multi-site clinical trial design. Major initiatives include scalable cloud pipelines, cost monitoring systems, and production-grade clinical decision support.